Genomic biomarkers to guide precision radiotherapy in prostate cancer-Reference-Cited by-全球学者库

Genomic biomarkers to guide precision radiotherapy in prostate cancer

Published:2022-06-03 Issue:S1 Volume:82 Page:
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Sutera Philip¹,Deek Matthew P.²,Van der Eecken Kim³,Wyatt Alexander W.⁴,Kishan Amar U.⁵,Molitoris Jason K.⁶,Ferris Matthew J.⁶,Siddiqui M. Minhaj⁷,Rana Zaker⁶,Mishra Mark V.⁶,Kwok Young⁶,Davicioni Elai⁸,Spratt Daniel E.⁹,Ost Piet¹⁰¹¹,Feng Felix Y.¹²,Tran Phuoc T.⁶^ORCID

Affiliation:

1. Department of Radiation Oncology and Molecular Radiation Sciences Johns Hopkins University School of Medicine Baltimore Maryland USA

2. Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey Robert Wood Johnson Medical School Rutgers University New Brunswick New Jersey USA

3. Department of Pathology Ghent University Hospital, Cancer Research Institute (CRIG) Ghent Belgium

4. Department of Urologic Sciences, Vancouver Prostate Centre University of British Columbia Vancouver British Columbia Canada

5. Department of Radiation Oncology UCLA Los Angeles California USA

6. Department of Radiation Oncology University of Maryland School of Medicine Baltimore Maryland USA

7. Department of Surgery University of Maryland School of Medicine Baltimore Maryland USA

8. Veracyte San Diego California USA

9. Department of Radiation Oncology University Hospitals Cleveland Ohio USA

10. Department of Radiation Oncology Iridium Network Antwerp Belgium

11. Department of Human Structure and Repair Ghent University Ghent Belgium

12. Departments of Radiation Oncology, Medicine and Urology UCSF San Francisco California USA

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24373

Reference154 articles.

1. Cancer Statistics, 2021

2. High-risk prostate cancer—classification and therapy

3. Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer

4. First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

5. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship of prostate cancer with mutations in tumour suppressor genes;Translational Medicine;2023-10-17

2. Radiotheranostics in advanced prostate cancer: Current and future directions;Prostate Cancer and Prostatic Diseases;2023-04-14

3. Genetics and genomics of prostate cancer and therapeutic implications;The Prostate;2022-06-03